Search Results - "Herrero, José I."

Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial by Mogna-Peláez, Paola, Riezu-Boj, José I., Milagro, Fermin I., Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Tobaruela-Resola, Ana Luz, Tur, Josep A., Martínez, J Alfredo, Abete, Itziar, Zulet, M. Angeles

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern. The disease is silent, and its diagnosis is often delayed…”
Get full text

Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD by Perdomo, Carolina M., Ezponda, Ana, Núñez-Córdoba, Jorge M., Herrero, José I., Bastarrika, Gorka, Frühbeck, Gema, Escalada, Javier

“…Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease morbimortality. However, it is not clear if NAFLD staging may help identify…”
Get full text

Impact of non-neurological complications in severe traumatic brain injury outcome by Corral, Luisa, Javierre, Casimiro F, Ventura, Josep L, Marcos, Pilar, Herrero, José I, Mañez, Rafael

“…Non-neurological complications in patients with severe traumatic brain injury (TBI) are frequent, worsening the prognosis, but the pathophysiology of systemic…”
Get full text

Epicardial and liver fat implications in albuminuria: a retrospective study by Perdomo, Carolina M, Martin-Calvo, Nerea, Ezponda, Ana, Mendoza, Francisco J, Bastarrika, Gorka, Garcia-Fernandez, Nuria, Herrero, José I, Colina, Inmaculada, Escalada, Javier, Frühbeck, Gema

“…Albuminuria is considered an early and sensitive marker of kidney dysfunction, but also an independent cardiovascular risk factor. Considering the possible…”
Get full text

Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation by Baroja‐Mazo, Alberto, Revilla‐Nuin, Beatriz, Bejar, África, Martínez‐Alarcón, Laura, Herrero, José I., El‐Tayeb, Ali, Müller, Christa E., Aparicio, Pedro, Pelegrín, Pablo, Pons, José A.

“…The artificial induction of tolerance in transplantation is gaining strength. In mice, a differential role of extracellular adenosine (eADO) for regulatory and…”
Get full text

Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment by Tobaruela-Resola, Ana Luz, Milagro, Fermín I, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José I, Mogna-Peláez, Paola, Tur, Josep A, Martínez, J Alfredo, Abete, Itziar, Zulet, M Ángeles

“…Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a worldwide leading cause of liver-related associated morbidities and mortality. Currently,…”
Get full text

Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease by Mogna-Peláez, Paola, Romo-Hualde, Ana, Riezu-Boj, José I., Milagro, Fermin I., Muñoz-Prieto, David, Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Monreal, J. Ignacio, Tur, Josep A., Martínez, Alfredo, Abete, Itziar, Zulet, M. Angeles

“…Nonalcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease in the world. New non-invasive diagnostic tools are needed to…”
Get full text

A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers by Perez-Diaz-Del-Campo, Nuria, Riezu-Boj, Jose I, Marin-Alejandre, Bertha A, Monreal, J Ignacio, Elorz, Mariana, Herrero, José I, Benito-Boillos, Alberto, Milagro, Fermín I, Bugianesi, Elisabetta, Tur, Josep A, Martinez, J Alfredo, Abete, Itziar, Zulet, M Angeles

“…Non-alcoholic fatty liver disease (NAFLD) development is linked to insulin resistance and influenced by environmental factors, but it also underlined a genetic…”
Get more information

Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages by D’Avola, Delia, Iñarrairaegui, Mercedes, Pardo, Fernando, Rotellar, Fernando, Marti, Pablo, Bilbao, José I., Martinez-Cuesta, Antonio, Benito, Alberto, Alegre, Felix, Mauleón, Erica, Herrero, José I., Quiroga, Jorge, Prieto, Jesus, Sangro, Bruno

“…Background The Barcelona Clinic Liver Cancer (BCLC) staging system recommends first-line therapy for each tumor stage. We evaluated the effect of compliance…”
Get full text

Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression by Pérez-Sanz, Fernando, Revilla-Nuin, Beatriz, Martínez-Alarcón, Laura, Herrero, José I, Ramírez, Pablo, Pons, José A, Baroja-Mazo, Alberto

“…BACKGROUND.Numerous studies have emphasized the genetic and phenotypic profiles of tolerant transplant patients. Moreover, different groups have defined…”
Get full text

Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention by Tobaruela-Resola, Ana Luz, Riezu-Boj, José Ignacio, Milagro, Fermín I., Mogna-Pelaez, Paola, Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A., Martínez, J. Alfredo, Abete, Itziar, Zulet, María Ángeles

“…Abstract Purpose Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) affects one-third of the global population. Despite its high prevalence,…”
Get full text

Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients by Grau-Carmona, Teodoro, Morán-García, Vicente, García-de-Lorenzo, Abelardo, Heras-de-la-Calle, Gabriel, Quesada-Bellver, Belén, López-Martínez, Jorge, González-Fernández, Camilo, Montejo-González, Juan C, Blesa-Malpica, Antonio, Albert-Bonamusa, Immaculada, Bonet-Saris, Alfonso, Herrero-Meseguer, José I, Mesejo, Alfonso, Acosta, Jose

“…Summary Background & aims To assess the effect of an enteral diet enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and anti-oxidants on…”
Get full text

Flipped Classroom Improves Results in Pathophysiology Learning: Results of a Nonrandomized Controlled Study by Herrero, Jose I, Quiroga, Jorge

“…The flipped classroom has become increasingly popular in health professions education. The aim of this study was to analyze its effect on learning in a…”
Get full text

Standard versus extended primary cytomegalovirus prophylaxis in solid organ transplantation by Serrano-Alonso, María, Martín-Moreno, Paloma, Rábago, Gregorio, Guillén-Grima, Francisco, Herrero, José I, Fernández-Alonso, Mirian

“…We compared the efficacy and safety of standard vs. extended primary cytomegalovirus (CMV) prophylaxis in solid organ transplantation. Retrospective cohort…”
Get more information

Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention by Tobaruela-Resola, Ana Luz, Riezu-Boj, José I, Milagro, Fermin I, Mogna-Pelaez, Paola, Herrero, José I, Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A, Martínez, J Alfredo, Abete, Itziar, Zulet, M Angeles

“…Metabolic dysfunction-associated steatotic liver disease (MASLD), with a prevalence of 30% of adults globally, is considered a multifactorial disease. There is…”
Get full text

A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids by Otero, Alejandra, Varo, Evaristo, de Urbina, Jorge Ortiz, Martín‐Vivaldi, Rafael, Cuervas‐Mons, Valentin, González‐Pinto, Ignacio, Rimola, Antoni, Bernardos, Angel, Otero, Santiago, Maldonado, Jorge, Herrero, Jose I., Barrao, Elena, Domínguez‐Granados, Rosa

“…This open‐label, randomized study compared the efficacy of a regimen of corticosteroids and tacrolimus (standard therapy group, n = 79) with a regimen of…”
Get full text

Prognostic factors and prevention of radioembolization‐induced liver disease by Gil‐Alzugaray, Belen, Chopitea, Ana, Iñarrairaegui, Mercedes, Bilbao, Jose I., Rodriguez‐Fraile, Macarena, Rodriguez, Javier, Benito, Alberto, Dominguez, Inés, D'Avola, Delia, Herrero, Jose I., Quiroga, Jorge, Prieto, Jesus, Sangro, Bruno

“…Radioembolization (RE)‐induced liver disease (REILD) has been defined as jaundice and ascites appearing 1 to 2 months after RE in the absence of tumor…”
Get full text

Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis by Yuste, Jose R, Serrano-Alonso, María, Carmona-Torre, Francisco, Del Pozo, Jose L, Herrero, Jose I

Get full text

Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial by Marin‐Alejandre, Bertha A., Cantero, Irene, Perez‐Diaz‐del‐Campo, Nuria, Monreal, Jose I., Elorz, Mariana, Herrero, Jose I., Benito‐Boillos, Alberto, Quiroga, Jorge, Martinez‐Echeverria, Ana, Uriz‐Otano, Juan I., Huarte‐Muniesa, Maria P., Tur, Josep A., Martinez, Jose A., Abete, Itziar, Zulet, Maria A.

“…Background and objectives Nonalcoholic fatty liver disease (NAFLD) management is focused on lifestyle modifications, but long‐term maintenance is a challenge…”
Get full text

Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma by Sangro, Bruno, Rios, Raquel, Bilbao, Ignacio, Beloqui, Oscar, Herrero, Jose I, Quiroga, Jorge, Prieto, Jesus

“…To analyze the results of an intra-arterially delivered combination chemotherapy in a group of patients with regionally advanced hepatocellular carcinoma…”
Get more information